13484-56-5

Basic information

• Product Name: 3-Chloro-6-Methoxypyrazin-2-aMine
• Synonyms: 3-Chloro-6-Methoxypyrazin-2-aMine;3-Amino-2-chloro-5-methoxypyrazine;3-chloro-6-methoxy-2-Pyrazinamine
• CAS NO: 13484-56-5
• Molecular Formula: C₅H₆ClN₃O
• Molecular Weight: 159.57364
• Mol File: 13484-56-5.mol
• Article Data: 4

Chemical Properties

• Melting Point: 115 °C
• Boiling Point: 269.4±35.0 °C(Predicted)
• Appearance: /
• Density: 1.398±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 1.51±0.10(Predicted)
• CAS DataBase Reference: 3-Chloro-6-Methoxypyrazin-2-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Chloro-6-Methoxypyrazin-2-aMine(13484-56-5)
• EPA Substance Registry System: 3-Chloro-6-Methoxypyrazin-2-aMine(13484-56-5)

Safety Data

• Hazardous Substances Data: 13484-56-5(Hazardous Substances Data)

Usage

General Description

3-Chloro-6-Methoxypyrazin-2-aMine is a chemical compound with a molecular formula C5H6ClN3O that belongs to the class of pyrazines. It is a derivative of pyrazine with a chlorine atom at the 3-position and a methoxy group at the 6-position. 3-Chloro-6-Methoxypyrazin-2-aMine is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It can also be used as a flavoring agent in food and beverages due to its pleasant aroma and taste. Additionally, 3-Chloro-6-Methoxypyrazin-2-aMine has been studied for its potential biological activity, including its antimicrobial and antioxidant properties. Overall, this compound has a range of applications in various industries and is of interest for its potential health benefits.

InChI:InChI=1S/C5H6ClN3O/c1-10-3-2-8-4(6)5(7)9-3/h2H,1H3,(H2,7,9)

Upstream product

• 6905-47-1 6-Methoxy-pyrazin-2-ylamine 

Relevant articles and documents

NEW ANTIBACTERIAL COMPOUNDS

The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.

PYRAZINYL 3-CYANOQUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF TUMOURS

The invention concerns quinoline derivatives of Formula I Formula (I) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)(R3) group wherein each R2 or R3 group is hydrogen or (1-8C)alkyl, m is 1, 2 or 3, each R1 group has any of the meanings defined in the description, Ra is hydrogen or halogeno, Rc is hydrogen, halogeno, (1-6C)alkyl or (1-6C)alkoxy, and Rd is (1-6C)alkoxy, or Rc and Rd together form a (1-3C)alkylenedioxy group, or a pharmaceutically-acceptable salt thereof; processes for their preparation; pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.